Hermann Brenner
Overview
Explore the profile of Hermann Brenner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
1588
Citations
55999
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lee M, Hatcher C, Hazelwood E, Goudswaard L, Tsilidis K, Vincent E, et al.
Int J Epidemiol
. 2025 Jan;
54(1).
PMID: 39846783
Background: Adiposity is an established risk factor for colorectal cancer (CRC). The pathways underlying this relationship, and specifically the role of circulating proteins, are unclear. Methods: Utilizing two-sample univariable Mendelian...
12.
Lohner V, Perna L, Schottker B, Perneczky R, Brenner H, Mons U
Exp Gerontol
. 2025 Jan;
200:112684.
PMID: 39824235
Background: In light of growing evidence highlighting interactions between cardiac and brain health, we investigated associations of biomarkers of neurodegenerative diseases with adverse outcomes (all-cause and cardiovascular mortality, major cardiovascular...
13.
Safizadeh F, Mandic M, Hoffmeister M, Brenner H
JAMA Netw Open
. 2025 Jan;
8(1):e2454753.
PMID: 39820694
Importance: The proportion of colorectal cancer (CRC) cases attributable to excess weight, known as population attributable fraction (PAF), has been commonly based on measures of body mass index (BMI). Central...
14.
Xie R, Seum T, Sha S, Trares K, Holleczek B, Brenner H, et al.
Cardiovasc Diabetol
. 2025 Jan;
24(1):18.
PMID: 39806417
Background: Existing cardiovascular risk prediction models still have room for improvement in patients with type 2 diabetes who represent a high-risk population. This study evaluated whether adding metabolomic biomarkers could...
15.
Brenner H, Holland-Letz T, Hoffmeister M, Heisser T
J Clin Epidemiol
. 2025 Jan;
180:111669.
PMID: 39800010
Objectives: Recently, results on colorectal cancer (CRC) incidence and mortality reduction by the offer of screening colonoscopy were reported for the first time from a randomized controlled trial (RCT), the...
16.
Safizadeh F, Mandic M, Hoffmeister M, Brenner H
Cancer Commun (Lond)
. 2025 Jan;
PMID: 39791283
No abstract available.
17.
Gauderman W, Fu Y, Queme B, Kawaguchi E, Wang Y, Morrison J, et al.
bioRxiv
. 2025 Jan;
PMID: 39763728
A polygenic risk score (PRS) is used to quantify the combined disease risk of many genetic variants. For complex human traits there is interest in determining whether the PRS modifies,...
18.
Sergeev D, Heisser T, Hoffmeister M, Brenner H
Int J Cancer
. 2025 Jan;
PMID: 39751766
Studies aimed to evaluate the expected impact of alternative screening strategies are essential for optimizing colorectal cancer (CRC) screening offers, but such studies are lacking in Germany, where two screening...
19.
Yiangou K, Mavaddat N, Dennis J, Zanti M, Wang Q, Bolla M, et al.
Breast Cancer Res
. 2024 Dec;
26(1):189.
PMID: 39734228
Background: The 313-variant polygenic risk score (PRS) provides a promising tool for clinical breast cancer risk prediction. However, evaluation of the PRS across different European populations which could influence risk...
20.
Xie R, Herder C, Sha S, Peng L, Brenner H, Schottker B
EClinicalMedicine
. 2024 Dec;
79:102971.
PMID: 39720612
Background: We aimed to evaluate the incremental predictive value of metabolomic biomarkers for assessing the 10-year risk of type 2 diabetes when added to the clinical Cambridge Diabetes Risk Score...